Active Ingredient: DIFLUNISAL
Proprietary Name: DIFLUNISAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074285
Product Number: 001
Approval Date: May 7, 1996
Applicant Holder Full Name: PUREPAC PHARMACEUTICAL CO
Marketing Status:
Discontinued
Patent and Exclusivity Information